Christopher Keel

Tulane University, University of Tennessee at Chattanooga

Papers

Total Citations

H-Index

About

Christopher Keel is a urologic surgeon and researcher whose work focuses on mitigating renal injury during minimally invasive kidney surgery and advancing robotic surgical techniques. His early research established a foundational method for quantifying oxidative stress in renal tissue, using isoprostane as a biomarker to measure ischemia-reperfusion injury following renal artery clamping—a critical concern in laparoscopic and robotic partial nephrectomy. This work, published in 2011, has garnered 14 citations and remains relevant for surgeons seeking to preserve kidney function during tumor resection. Keel also pioneered a novel robotic approach to inguinal lymph node dissection for melanoma, addressing a technically challenging procedure with a minimally invasive alternative. His 2018 paper on this technique, cited 11 times, demonstrates his commitment to improving surgical outcomes through innovation. By bridging the gap between basic science and clinical application, Keel has contributed to safer, more effective urologic oncology procedures, earning recognition for his efforts to reduce patient morbidity and expand the capabilities of robotic surgery.